Rapidly assess drug response in 2D and 3D breast cancer model systems with a luminescent viability assay

4 Mar 2024

In recent years, the culture of cancer cells, along with other cell types, in three-dimensional (3D) formats where they can form multi-layered structures is enabling new models for cancer research that are considered more biologically relevant. In this application note from Molecular Devices, explore a small-scale study of cell viability in 2D and 3D cell cultures, measured using the CellTiter-Glo® 3D Cell Viability assay (Promega). Discover how Molecular Devices assayed the viability of two cell types grown in 2D and 3D and challenged with several previously tested compounds.

SpectraMax® Microplate Readers

Molecular Devices®

The SpectraMax® line of user-friendly microplate readers provide great flexibility for labs conducting applications ranging from ELISAs to nucleic acid and protein quantitation, and include absorbance, fluorescence, luminescence and more

(11)

Links

Tags

Rapidly assess drug response in 2D and 3D breast cancer model systems with a luminescent viability assay